ENDOSIDE

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	03-03-2026	150 d early	2026-00048537
31-12-2024	31-07-2025	28-08-2025	28 d late	2025-00478757
31-12-2023	31-07-2024	19-07-2024	12 d early	2024-00268747

Metric	This company	Sector median	Position in the sector
Solvency	97.1%	58.1%	better than 95% of 2210 sector peers
Net result	€72k	€60k	better than 56% of 2208 sector peers
Equity	€161k	€74k	better than 71% of 2210 sector peers
Gross operating margin	€94k	€96k	better than 49% of 2210 sector peers
Total assets	€166k	€186k	better than 45% of 2210 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€166k
Fixed assets	21/28	€3k
Tangible fixed assets	22/27	€3k
Current assets	29/58	€163k
Amounts receivable within one year	40/41	€49k
Cash & bank	54/58	€113k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€166k
Equity	10/15	€161k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€158k
Amounts payable	17/49	€5k
Amounts payable within one year	42/48	€5k
Trade debts payable within one year	44	€926
Income statement
Gross operating margin	9900	€94k
Operating result	9901	€90k
Financial income	75	€2k
Financial charges	65	€125
Result before taxes	9903	€92k
Income taxes	67/77	€19k
Net result for the period	9904	€72k
Result to be appropriated	9905	€72k

Summary